$99M sweet spot round size
Most of their 15 investments are in rounds between $37M and $220M
2019
Senda Biosciences raised $123M on August 16, 2022
Investors: Qatar Investment Authority, Flagship Ventures, STAGE 1 VENTURES, LLC, Mayo Clinic, Center for Innovation, Partners Investment and Longevity Vision Fund
Tessera Therapeutics raised $300M on April 19, 2022
Investors: ARTIS Ventures, Flagship Ventures, SoftBank Investment Advisers, March Capital, T. Rowe Price and Longevity Vision Fund
Biolinq raised $100M on November 2, 2021
Investors: The Broe Group, RiverVest Venture Partners, Global Health Funds, JDRF T1D Fund, M Ventures, Hikma Ventures and Longevity Vision Fund
Laronde raised $440M on August 30, 2021
Investors: The Invus Group, T. Rowe Price, Flagship Ventures and Longevity Vision Fund
Exo raised $220M on July 29, 2021
Investors: Avidity Partners, Pura Vida Investments, Page One Ventures, RA Capital Management, L.P., Sands Capital Management and Longevity Vision Fund
Senda Biosciences raised $98M on June 10, 2021
Investors: Mayo Clinic, Center for Innovation, MINT Venture Partners, Partners Investment and Longevity Vision Fund
Tessera Therapeutics raised $230M on January 12, 2021
Investors: Alaska Permanent Fund Corporation, Qatar Investment Authority, SoftBank Investment Advisers, Flagship Ventures and Longevity Vision Fund
LyGenesis raised $11M on December 30, 2020
Investors: Juvenescence and Longevity Vision Fund
Undisclosed raised $65M on November 9, 2020
Investors: Questa Capital Management, ARTIS Ventures, Sand Hill Angels, DigiTx Partners, HCP Ltd, NTTVC and Longevity Vision Fund
Deep Longevity raised undisclosed on July 14, 2020
Investors: LongeVC, Formic Ventures, BOLD Capital Partners and Longevity Vision Fund